Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20.

Monitoring and assessing vaccine safety: a European perspective.

Author information

1
European Centre for Disease Prevention and Control, SE-171 83 Stockholm, Sweden. pierluigi.lopalco@ecdc.europa.eu

Abstract

The success of vaccination programs is an uncontroversial reality--in Europe as well as worldwide. On the other hand, the perceived risk of adverse events in the general public is the most important threat for implementing successful vaccination programs in Europe. For this reason, monitoring and assessing vaccine safety is a priority for public health. Vaccine safety is assessed both before and after vaccine authorization. In postmarketing settings, different activities related to vaccine safety usually involve several different stakeholders. In 2005, a new EU agency, the European Centre for Disease Prevention and Control, was established with the aim to strengthen Europe's defences against infectious diseases. Implementing stable links between different stakeholders and defining clear roles in the EU is paramount in order to provide optimal and transparent information on adverse reactions following immunization, with the final goal of increasing compliance to safe and effective vaccination programs.

PMID:
20370548
DOI:
10.1586/erv.10.20
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center